Healthcare provider profile · identity verified

Jacinta Catherine Eickholt, M.D.

Family Practice · LIMA, OH · NPI 1356500805

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Furosemide	Furosemide	310	39
Potassium Chloride	Potassium Chloride	310	42
Atorvastatin Calcium	Atorvastatin Calcium	250	47
Pantoprazole Sodium	Pantoprazole Sodium	237	41
Metoprolol Succinate	Metoprolol Succinate	208	33
Levothyroxine Sodium	Levothyroxine Sodium	201	35
Sertraline Hcl	Sertraline Hcl	174	21
Eliquis	Apixaban	159	20
Lisinopril	Lisinopril	149	18
Amlodipine Besylate	Amlodipine Besylate	146	21
Metoprolol Tartrate	Metoprolol Tartrate	144	24
Trazodone Hcl	Trazodone Hcl	132	27
Gabapentin	Gabapentin	131	21
Buspirone Hcl	Buspirone Hcl	114	19
Duloxetine Hcl	Duloxetine Hcl	102	12
Omeprazole	Omeprazole	94	15
Allopurinol	Allopurinol	91	12
Losartan Potassium	Losartan Potassium	90	14
Bumetanide	Bumetanide	80	16
Donepezil Hcl	Donepezil Hcl	78	15
Carbidopa-Levodopa	Carbidopa/Levodopa	73	suppressed
Metformin Hcl	Metformin Hcl	72	12
Divalproex Sodium	Divalproex Sodium	71	11
Januvia	Sitagliptin Phosphate	71	suppressed
Hydralazine Hcl	Hydralazine Hcl	70	11
Escitalopram Oxalate	Escitalopram Oxalate	69	12
Mirtazapine	Mirtazapine	59	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	58	suppressed
Levetiracetam	Levetiracetam	57	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	56	suppressed
Bupropion Xl	Bupropion Hcl	53	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	52	suppressed
Ropinirole Hcl	Ropinirole Hcl	52	suppressed
Spironolactone	Spironolactone	52	suppressed
Famotidine	Famotidine	51	12
Hydrochlorothiazide	Hydrochlorothiazide	51	suppressed
Lorazepam	Lorazepam	50	24
Simvastatin	Simvastatin	50	suppressed
Clopidogrel	Clopidogrel Bisulfate	49	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	48	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	45	suppressed
Prednisone	Prednisone	45	suppressed
Valsartan	Valsartan	45	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	44	18
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	41	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	41	suppressed
Finasteride	Finasteride	39	suppressed
Latanoprost	Latanoprost	39	suppressed
Risperidone	Risperidone	39	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	37	suppressed
Xarelto	Rivaroxaban	36	suppressed
Amiodarone Hcl	Amiodarone Hcl	35	suppressed
Warfarin Sodium	Warfarin Sodium	35	suppressed
Torsemide	Torsemide	34	suppressed
Baclofen	Baclofen	33	suppressed
Sucralfate	Sucralfate	33	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	30	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	30	suppressed
Alendronate Sodium	Alendronate Sodium	29	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	29	18
Oxybutynin Chloride Er	Oxybutynin Chloride	29	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	29	suppressed
Valproic Acid	Valproic Acid	29	suppressed
Citalopram Hbr	Citalopram Hydrobromide	27	suppressed
Tizanidine Hcl	Tizanidine Hcl	27	suppressed
Atenolol	Atenolol	25	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	25	suppressed
Clonidine Hcl	Clonidine Hcl	25	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	25	suppressed
Memantine Hcl	Memantine Hcl	25	suppressed
Montelukast Sodium	Montelukast Sodium	25	suppressed
Movantik	Naloxegol Oxalate	25	suppressed
Lamotrigine	Lamotrigine	24	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	24	suppressed
Jardiance	Empagliflozin	23	suppressed
Metformin Hcl Er	Metformin Hcl	23	suppressed
Albuterol Sulfate	Albuterol Sulfate	21	15
Fluticasone Propionate	Fluticasone Propionate	21	13
Ondansetron Odt	Ondansetron	21	11
Carvedilol	Carvedilol	20	suppressed
Myrbetriq	Mirabegron	20	suppressed
Pravastatin Sodium	Pravastatin Sodium	20	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	19	12
Metolazone	Metolazone	19	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	suppressed
Ondansetron Hcl	Ondansetron Hcl	19	12
Terazosin Hcl	Terazosin Hcl	19	suppressed
Ezetimibe	Ezetimibe	17	suppressed
Gemtesa	Vibegron	17	suppressed
Glipizide	Glipizide	17	suppressed
Loperamide	Loperamide Hcl	17	suppressed
Midodrine Hcl	Midodrine Hcl	17	suppressed
Nifedipine Er	Nifedipine	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	16	11
Cephalexin	Cephalexin	16	suppressed
Scopolamine	Scopolamine	16	suppressed
Azithromycin	Azithromycin	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	11
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Enulose	Lactulose	15	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	15	suppressed
Oxycodone Hcl	Oxycodone Hcl	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	suppressed
Arnuity Ellipta	Fluticasone Furoate	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Glimepiride	Glimepiride	13	suppressed
Levofloxacin	Levofloxacin	13	suppressed
Namzaric	Memantine Hcl/Donepezil Hcl	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	13	suppressed
Verapamil Sr	Verapamil Hcl	13	suppressed
Colchicine	Colchicine	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Divalproex Sodium Er	Divalproex Sodium	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Leflunomide	Leflunomide	12	suppressed
Levocarnitine	Levocarnitine	12	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	12	suppressed
Rivastigmine	Rivastigmine	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Memantine Hcl Er	Memantine Hcl	11	suppressed
Morphine Sulfate	Morphine Sulfate	11	11
Tramadol Hcl	Tramadol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error